Loading market dashboard
Syndax Pharmaceuticals, Inc.
SNDXHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Syndax Pharmaceuticals, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $1.10B | $956.81M - $1.28B | $42.33M | $3.123 | 5 |
| Dec 2029 | $907.68M | $789.12M - $1.06B | $34.91M | $2.194 | 5 |
| Dec 2028 | $693.44M | $693.43M - $693.45M | $26.67M | $0.651 | 11 |
| Dec 2027 | $509.75M | $459.48M - $606.03M | $19.61M | -$0.587 | 9 |
| Dec 2026 | $345.49M | $322.53M - $367.76M | $13.29M | -$1.787 | 9 |
| Dec 2025 | $168.15M | $163.00M - $173.85M | $6.47M | -$3.103 | 7 |
| Dec 2024 | $48.27M | $22.86M - $134.33M | $1.86M | -$3.476 | 9 |
| Dec 2023 | $3.50M | $3.04M - $4.08M | $134.6K | -$3.376 | 5 |
| Dec 2022 | $375.0K | $294.2K - $431.6K | $14.4K | -$2.531 | 3 |
| Dec 2021 | $19.15M | $15.02M - $22.04M | $736.6K | -$2.042 | 4 |
| Dec 2020 | $1.47M | $1.15M - $1.69M | $56.4K | -$1.864 | 4 |
| Dec 2019 | $1.50M | $1.17M - $1.72M | $57.6K | -$1.825 | 3 |